Please login to the form below

Not currently logged in
Email:
Password:

Altana Pharma

This page shows the latest Altana Pharma news and features for those working in and with pharma, biotech and healthcare.

Altana snapped up

ìIt's an acquisition in the sense that we are buying Altana's pharma division but it's also a merger in the sense that we will have to work with ... Altana Pharma CEO, Dr. Hans-Joachim Lohrisch, has agreed to join the Nycomed board, which Dr Bjˆrklund

Latest news

  • Deal frenzy continues

    UCB's agreed takeover of Schwarz Pharma adds to the flurry of recent deals, giving analysts plenty to talk about. ... Two other significant mergers have already been announced; Merck KGaA's takeover of Serono and Nycomed's acquisition of Altana Pharma.

  • Pharma news in brief

    Altana raises hopes. Sales at Altana Pharma are up 9 per cent to Ä1.1bn for the first half of the year boosted by sales in its therapeutic division, which went ... Buoyed by current figures, Altana Pharma has forecast an 8-10 per cent rise in sales for

  • New accounts: March

    Abbott Laboratories. Humira. Rheumatoid arthritis. Brader Perryman. Altana Pharma. Alvesco. Asthma. ... MJL Advertising. Merck Pharma. Glucophage SR. Diabetes. PBC Comms. Merck Sharp &Dohme.

  • PMEA 2006: Winners in pictures

    by UCB Pharma. in association with Junction 11. European Marketing Campaign of the Year. ... Highly Commended. ALTANA Pharma - From Vision to Reality. submitted by Packer Forbes Communications.

  • New Accounts, May, 2006 - Advertising

    Woolley Pau. Actelion Pharmaceuticals. Tracleer. Cardiovascular. Woolley Pau. Altana Pharma. Alvesco.

More from news
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest appointments

  • bmore creative hires Kush Rach as new business director bmore creative hires Kush Rach as new business director

    He was a key account manager at the pharma company, where he worked in the diabetes therapeutic area, and was involved in the UK launch of Galvus (vildagliptin) for type 2 ... Having gained his degree in pharmacology at University of Aberdeen, Rach

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics